G-Protein-Coupled Receptor (GPCR) Signaling and Pharmacology in Metabolism: Physiology, Mechanisms, and Therapeutic Potential
Biomolecules · 15.02.2025 · 15 (2) · 291
DOI: 10.3390/biom15020291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 15.02.2025. Verfasst von Yun Yeong Cho und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Signal Transduction, Metabolic Diseases. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Institute for Advancement of Technology, Yonsei University Research Fund.
Abstract (Originalsprache)
G-protein coupled receptors (GPCRs), the largest family of integral membrane proteins, enable cells to sense and appropriately respond to the environment through mediating extracellular signaling to intercellular messenger molecules. GPCRs’ pairing with a diverse array of G protein subunits and related downstream secondary messengers, combined with their ligand versatility-from conventional peptide hormone to numerous bioactive metabolites, allow GPCRs to comprehensively regulate metabolism and physiology. Consequently, GPCRs have garnered significant attention for their therapeutic potential in metabolic diseases. This review focuses on six GPCRs, GPR40, GPR120, GLP-1R, and ß-adrenergic receptors (ADRB1, ADRB2, and ADRB3), with GLP-1R recognized as a prominent regulator of system-level metabolism, while the roles of GPR40, GPR120 and ß-adrenergic receptors in central carbon metabolism and energy homeostasis are increasingly appreciated. Here, we discuss their physiological functions in metabolism, the current pharmacological landscape, and the intricacies of their signaling pathways via G protein and ß-arrestin activation. Additionally, we discuss the limitations of existing GPCR-targeted strategies for treating metabolic diseases and offer insights into future perspectives for advancing GPCR pharmacology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea.
- Department of Biological Sciences, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
ORCID-Profile: Pankyung Kim, Su Myung Jung, Hye Jin Kang
Förderung
- National Research Foundation of Korea
- Korea Institute for Advancement of Technology
- Yonsei University Research Fund
- National Research Foundation of Korea (NRF) grants funded by the Korean Government (MSIT)
- Korea Institute for Advancement of Technology (KIAT) funded by the Ministry of Trade, Industry and Energy in 2024
Zitieren
APA
Cho, Y. Y., Kim, S., Kim, P., Jo, M. J., Park, S. E., Choi, Y., Jung, S. M., & Kang, H. J. (2025). G-Protein-Coupled Receptor (GPCR) Signaling and Pharmacology in Metabolism: Physiology, Mechanisms, and Therapeutic Potential. Biomolecules, 15(2), 291. https://doi.org/10.3390/biom15020291
Vancouver
Cho YY, Kim S, Kim P, Jo MJ, Park SE, Choi Y, et al. G-Protein-Coupled Receptor (GPCR) Signaling and Pharmacology in Metabolism: Physiology, Mechanisms, and Therapeutic Potential. Biomolecules. 2025;15(2):291. doi:10.3390/biom15020291
BibTeX
@article{Cho2025,
author = {Cho, Yun Yeong and Kim, Soyeon and Kim, Pankyung and Jo, Min Jeong and Park, Song-E and Choi, Yiju and Jung, Su Myung and Kang, Hye Jin},
title = {G-Protein-Coupled Receptor (GPCR) Signaling and Pharmacology in Metabolism: Physiology, Mechanisms, and Therapeutic Potential},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {2},
pages = {291},
doi = {10.3390/biom15020291}
}
EUVIMED